Bow bridge in Central park at spring sunny day, New York City

How Ozempic Maker Novo Nordisk Lost Its Shine

Start

The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed its fortunes.

Previous Story

Lawrence A. Bossidy, Who Led a Major Corporate Turnaround, Dies at 90

Next Story

Pill Causes Major Weight Loss in Eli Lilly Trial’s Results